| Inhibition of LFA‐1/ICAM‐1 and VLA‐4/VCAM‐1 as a therapeutic approach to inflammation and autoimmune diseases H Yusuf‐Makagiansar, ME Anderson, TV Yakovleva, JS Murray, ... Medicinal research reviews 22 (2), 146-167, 2002 | 520 | 2002 |
| The role of thiols and disulfides on protein stability MV Trivedi, JS Laurence, TJ Siahaan Current Protein and Peptide Science 10 (6), 614-625, 2009 | 416 | 2009 |
| Improvement of oral peptide bioavailability: Peptidomimetics and prodrug strategies GM Pauletti, S Gangwar, TJ Siahaan, J Aubé, RT Borchardt Advanced drug delivery reviews 27 (2-3), 235-256, 1997 | 304 | 1997 |
| Drug delivery: principles and applications B Wang, L Hu, TJ Siahaan John Wiley & Sons, 2016 | 264 | 2016 |
| PLGA nanoparticle− peptide conjugate effectively targets intercellular cell-adhesion molecule-1 N Zhang, C Chittasupho, C Duangrat, TJ Siahaan, C Berkland Bioconjugate chemistry 19 (1), 145-152, 2008 | 240 | 2008 |
| Solution stability of linear vs. cyclic RGD peptides SJ Bogdanowich‐Knipp, S Chakrabarti, TJ Siahaan, TD Williams, ... The Journal of peptide research 53 (5), 530-541, 1999 | 236 | 1999 |
| Structural requirements for intestinal absorption of peptide drugs GM Pauletti, S Gangwar, GT Knipp, MM Nerurkar, FW Okumu, K Tamura, ... Journal of controlled release 41 (1-2), 3-17, 1996 | 234 | 1996 |
| ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells C Chittasupho, SX Xie, A Baoum, T Yakovleva, TJ Siahaan, CJ Berkland European journal of pharmaceutical sciences 37 (2), 141-150, 2009 | 220 | 2009 |
| Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors ME Anderson, TJ Siahaan Peptides 24 (3), 487-501, 2003 | 189 | 2003 |
| Cell adhesion molecules for targeted drug delivery AL Dunehoo, M Anderson, S Majumdar, N Kobayashi, C Berkland, ... Journal of pharmaceutical sciences 95 (9), 1856-1872, 2006 | 181 | 2006 |
| Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: A combinational approach for enhanced delivery of nanoparticles M Norouzi, V Yathindranath, JA Thliveris, BM Kopec, TJ Siahaan, ... Scientific reports 10 (1), 11292, 2020 | 178 | 2020 |
| Peptide‐mediated targeted drug delivery S Majumdar, TJ Siahaan Medicinal research reviews 32 (3), 637-658, 2012 | 164 | 2012 |
| Pathways and progress in improving drug delivery through the intestinal mucosa and blood–brain barriers M Laksitorini, VD Prasasty, PK Kiptoo, TJ Siahaan Therapeutic delivery 5 (10), 1143-1163, 2014 | 143 | 2014 |
| Separation and analysis of peptides and proteins C Schoneich, AFR Huhmer, SR Rabel, JF Stobaugh, SDS Jois, CK Larive, ... Analytical chemistry 67 (12), 155-181, 1995 | 115 | 1995 |
| VEGF-A stimulation of leukocyte adhesion to colonic microvascular endothelium: implications for inflammatory bowel disease S Goebel, M Huang, WC Davis, M Jennings, TJ Siahaan, JS Alexander, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 290 (4 …, 2006 | 112 | 2006 |
| Effect of restricted conformational flexibility on the permeation of model hexapeptides across Caco-2 cell monolayers FW Okumu, GM Pauletti, DG Vander Velde, TJ Siahaan, RT Borchardt Pharmaceutical research 14, 169-175, 1997 | 110 | 1997 |
| The effect of conformation on the solution stability of linear vs. cyclic RGD peptides SJ Bogdanowich‐Knipp, DSS Jois, TJ Siahaan The Journal of peptide research 53 (5), 523-529, 1999 | 104 | 1999 |
| The effect of β-turn structure on the passive diffusion of peptides across Caco-2 cell monolayers GT Knipp, DG Vander Velde, TJ Siahaan, RT Borchardt Pharmaceutical research 14, 1332-1340, 1997 | 104 | 1997 |
| Protein PEGylation for cancer therapy: bench to bedside V Gupta, S Bhavanasi, M Quadir, K Singh, G Ghosh, K Vasamreddy, ... Journal of Cell Communication and Signaling 13, 319-330, 2019 | 99 | 2019 |
| Controlling ligand surface density optimizes nanoparticle binding to ICAM-1 A Fakhari, A Baoum, TJ Siahaan, KB Le, C Berkland Journal of pharmaceutical sciences 100 (3), 1045-1056, 2011 | 99 | 2011 |
Cory BerklandThe University of KansasVerified email at ku.edu
